1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA C12orf65 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA ACACA CTRPv2 pan-cancer AAC -0.089 0.01
mRNA EVPL CTRPv2 pan-cancer AAC 0.1 0.01
mRNA LAIR1 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA TAF3 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA OGG1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CYP27A1 CTRPv2 pan-cancer AAC 0.099 0.01
mRNA LYPD8 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA ZKSCAN1 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA GPHN CTRPv2 pan-cancer AAC 0.089 0.01
Download CSV